Cancer Weekly articles from October 2003

Cancer Weekly archives from October 2003

Researchers identify cancer stem cell for brain tumors.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- A research team at the Hospital for Sick Children (HSC) and the University of Toronto (U of T), led by Dr. Peter Dirks, has identified for the first time a cancer stem cell in both malignant and benign...

The von Hippel-Lindau protein targets hsRPB7 to regulate angiogenesis.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- The von Hippel-Lindau protein targets hsRPB7 to regulate angiogenesis According to recent research from the United States, "inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene is...

Patients offer recommendations for care to their physicians.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Patients with breast cancer offer recommendations for care to their physicians. "Women enter an increasingly complex medical system when they receive the diagnosis of breast cancer. Subsequently,...

Hemoglobin causes malignant cells to release matrix metalloproteinase-9.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Hemoglobin causes malignant cells to release matrix metalloproteinase-9. According to recent research published in the journal Blood Coagulation and Fibrinolysis, "matrix metalloproteinase-9 (MMP-9)...

Certain enzyme inhibitors show promise.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Certain enzyme inhibitors may slow tumor formation within weeks and could lead to treatments that retard or prevent recurrences of cancers, researchers at University of Texas Southwestern Medical Center...

New blood test could detect disease in its earliest stages.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Lung cancer is often deadly by the time doctors have detected it, but scientists at Duke University Medical Center are developing a noninvasive test that could detect lung cancer in its earliest stages,...

Polymorphism in codon 10 of ERalpha may be a risk factor for prostate cancer.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Polymorphism in codon 10 of ERalpha may be a risk factor for prostate cancer. "Estrogen receptor (ER) polymorphisms have been shown to be involved in the oncogenesis of several organs. We...

Incyte enters licensing agreement for a phase II HIV drug.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Incyte Corp. (INCY) and Pharmasset, Ltd., announced that they have entered into a collaborative licensing agreement to develop and commercialize the antiretroviral drug Reverset, also known as RVT,...

Functional FAS promoter polymorphisms are associated with increased risk of AML.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Functional FAS promoter polymorphisms are associated with increased risk of AML. "The FAS (TNFRSF6/CD95/APO-1) gene is silenced in many tumor types, resulting in an inability to respond to...

Some cancers may result from Agent Orange exposure.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Certain cancers may result from Agent Orange exposure. "Approximately 3 million Americans served in the armed forces in Vietnam during the Vietnam War," investigators in the United States report....

Marine-derived anticancer agents are evaluated in clinical trials.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Marine-derived anticancer agents are evaluated in clinical trials. According to a study from Brazil, "Anticancer agents may be derived either from the isolation of an active lead compound occurring...

Immunotherapeutic approaches to prostate cancer therapy are improving.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Immunotherapeutic approaches for prostate cancer increase with knowledge of how to stimulate anticancer immune responses. According to a study from the United States, "The components of an...

Consuming dietary antioxidant supplements has pros and cons for any population.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Consuming dietary antioxidant supplements has pros and cons for any population. "The health-related effects of interactions between reactive oxygen species (ROS) and dietary antioxidants and the...

Company announces discovery of positively charged cardiolipin.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- NeoPharm, Inc., (NEOL) announced that it has discovered new analogs of cationic (positively charged) cardiolipin for use in the company's NeoLipid liposomal system. Results were presented via...

Novel mechanisms of apoptosis induced by histone deacetylase inhibitors.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Novel mechanisms of apoptosis can be induced by histone deacetylase inhibitors. "Histone deacetylase inhibitors (HDACIs) are a new class of chemotherapeutic drugs able to induce tumor cell apoptosis...

PS-341 enhances TRAIL-induced apoptosis by increasing the cleavage of caspase 8.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- PS-341 enhances TRAIL-induced apoptosis by increasing the cleavage of caspase 8. "We demonstrate that PS-341, a small molecule inhibitor of the proteasome, markedly sensitizes resistant prostate,...

Pifithrin-alpha promotes p53-mediated apoptosis in JB6 cells.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Pifithrin-alpha promotes p53-mediated apoptosis in JB6 cells. According to recent research from the United States, "Recently, blockage of p53-dependent transcriptional activation and apoptosis by...

Folkman honored for hypertension research.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Judah Folkman, MD, is the winner of this year's Novartis Award for Hypertension Research. He is a pioneer in the field of angiogenesis. His work has led to a better understanding of how angiogenesis is...

Prior lymphoplasmacytic lymphoma is linked to diffuse large B-cell lymphoma.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia have a risk of developing diffuse large B cell lymphoma at the same time as, or following, the initial disease. According to a...

Bacillus subtilis extracytoplasmic function protein examined.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Scientists have investigated regulation of the Bacillus subtilis extracytoplasmic function protein sigma[superscript]Y and its target promoters. "The Bacillus subtilis extracytoplasmic function...

Radiation potentiates the effects of antiangiogenic agents on neuroblastoma.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Radiation potentiates the effects of antiangiogenic agents on neuroblastoma. According to recent research published in the International Journal of Cancer, "in spite of aggressive therapy, children...

Population pharmacokinetics of low-dose paclitaxel evaluated in brain tumors.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Population pharmacokinetics of low-dose paclitaxel was evaluated in patients with brain tumors. According to a study from Germany, "Our aim was to assess the pharmacokinetics of a low-dose schedule...

Survivin, an apoptosis inhibitor, is widely expressed in brain tumors.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Survivin, an apoptosis inhibitor, is widely expressed by brain tumors and may be a good immunotherapeutic target. According to published research from Switzerland, "Survivin, a member of the...

BMI and c-erbB-2 expression may be risk factors for contralateral breast cancer.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- BMI and c-erbB-2 expression may be risk factors for contralateral breast cancer. According to published research from the United States, "Women diagnosed with a first breast cancer before the age of...

Breast cancer mortality in the Netherlands has been decreasing since 1997.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Breast cancer mortality in The Netherlands has been decreasing since 1997. "The Netherlands breast cancer screening program for women aged 50 - 75 years was gradually implemented during 1989 -...

Brk promotes breast carcinoma cell proliferation.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Brk promotes breast carcinoma cell proliferation. "Brk (PTK6) is a nonreceptor protein tyrosine kinase, which is expressed in over 60% of breast carcinoma tissue samples and breast tumor cell...

Can healthy bones help prevent metastasis?
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Bones are the most common place in the body where breast cancer spreads, or metastasizes. Physicians at Fox Chase Cancer Center, Philadelphia, Pennsylvania, are studying the drug clodronate to see if it...

Chest wall ports can be placed ipsilateral to axillary lymph node dissection.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Chest wall ports can be placed ipsilateral to axillary lymph node dissection. "Without scientific evidence, practice has been to avoid placing chest wall ports ipsilateral to axillary lymph node...

Docetaxel and capecitabine improve survival in metastatic breast cancer.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Docetaxel and capecitabine improve survival in metastatic breast cancer. "Docetaxel (Taxotere) and capecitabine (Xeloda) demonstrate synergy in preclinical studies and both show high single-agent...

Exemestane demonstrates clinical benefit in advanced disease.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Results of a Phase II clinical trial indicate that the aromatase inhibitor exemestane demonstrates a high response rate for first-line treatment of advanced breast cancer in postmenopausal women. ...

Genetic clues may show which women face risk from HRT.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- A genetic clue may eventually help physicians identify certain women who would face an increased risk of breast cancer from using hormone replacement therapy. Researchers from the Keck School of...

Glitazones' mechanism of inhibiting tumor growth determined.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Researchers at Georgetown University's Lombardi Comprehensive Cancer Center have decoded the step-by-step process by which a class of popular anti-diabetes drugs inhibits cancerous tumor growth. ...

Low fat/high fiber diet doesn't appear to reduce risk.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- A diet low in fat and high in fiber reduces levels of circulating ovarian hormones, such as estrogen and progesterone, but not enough to have significant effect in reducing a woman's risk of breast...

Malathion alters cell adhesion of cultured breast carcinoma cells.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Malathion alters cell adhesion of cultured breast carcinoma cells. "We have studied the effects of the organophosphorous pesticide malathion on cell viability, actin cytoskeleton, cell adhesion...

Mammographic screening program in Australia evaluated.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- The organized mammographic screening program in Australia is evaluated. According to recent research from Australia, "An organized approach to mammographic screening in Australia commenced in 1992...

New technology could improve detection.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Teams of radiologists, scientists, and radiographers from the University of Aberdeen, the University of Manchester, and the South Manchester University Hospitals Trust, all in the U.K., will be using...

Patients treated by low-workload surgeons had poorer survival.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Patients treated by low-workload surgeons had poorer survival. "The formation of multidisciplinary breast teams across the UK is intended to concentrate the assessment and treatment of breast cancer...

Phase II clinical trial of MDX-010 launched.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Medarex, Inc., (MEDX) announced the initiation of a phase II clinical trial of MDX-010, a fully human anti-CTLA-4 antibody, for patients with metastatic breast cancer. This multicenter, open-label,...

Positive results of preclinical trials of AZ-CINN 310 released.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- CryoLife, Inc.'s (CRY), subsidiary, Aurazyme Pharmaceuticals, Inc., announced that in preclinical animal trials AZ-CINN-310 demonstrated accelerated destruction of breast cancer tumor cells at the site...

Some types of tumors behave in an unexpected way.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Tumor size may not be an accurate method of predicting lymph node involvement and disease progression in some breast cancers, according to investigators at the Research Institute of the McGill...

Study tests examestane for use after 5 years of preventive tamoxifen.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Doctors recommend that many postmenopausal women with breast cancer take tamoxifen for 5 years after treatment to prevent recurrence of their cancer. There is no standard therapy given after 5 years of...

The potential for cytogenetic effects may persist with low-energy X-ray use.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- The potential for cytogenetic effects may persist with low-energy X-ray use. According to published research from Germany, "low energy X-rays (E-ph less than or equal to50 keV) are widely used in...

Ultrasound may be an adjunct to mammography in diagnosing breast masses.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Ultrasound may be an adjunct to mammography in diagnosing breast masses. According to recent research published in the journal Physics in Medicine and Biology, "Classification of breast masses in...

cDNA microarray profiling identifies 5-fluorouracil-inducible target genes.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- cDNA microarray profiling identifies 5-fluorouracil-inducible target genes. According to a study from Northern Ireland, "The fluoropyrimidine 5-Fluorouracil (5-FU) is widely used in the treatment...

Sodium salicylate may be used to protect cells against deleterious stressors.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Sodium salicylate may be used to protect cells against deleterious stressors. According to recent research published in the European Journal of Biochemistry, "As heat shock proteins (Hsps) are...

GeneMax Corp. announces agreement for the production of TAP cancer vaccine.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- GeneMax Corp. (GMXX) announced an amended contractual agreement with Molecular Medicine BioServices, Inc., of San Diego, California, for the production of its clinical vector for delivery of the TAP...

Chromosomal instability is an early driving force of cancer progression.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Chromosomal instability is an early driving force of cancer progression. According to published research from the United States, "In this paper, we derive analytic solutions of stochastic...

Zoledronic acid is effective in managing metastatic bone disease.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Zoledronic acid is effective in managing metastatic bone disease According to published research from Scotland, "Many advanced cancers, particularly breast cancer and prostate cancer, metastasize to...

Zoledronic acid is the preferred therapy for treatment of bone metastases.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Zoledronic acid is the preferred therapy for treatment of bone metastases. According to published research from Belgium, "Various primary malignancies develop bone metastases, and the resultant...

Longer commute for cancer treatment associated with better survival.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Cancer patients who travel more than 15 miles for treatment appear to survive longer than patients who live closer to their treatment center, even after controlling for factors such as disease stage and...

Genetic differences revealed by SNPS play a role in risk, prevention, outcomes.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Roughly 99.9% of your genetic makeup is identical to every other human being, which makes the remaining tenth of a percent all the more interesting. Scientists around the world are feverishly...

Lysophosphatidic acid signaling has role in cancer progression.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Lysophosphatidic acid signaling has role in cancer progression. According to a study from the United States, "Lysophosphatidic acid (LPA) promotes growth, differentiation, survival and motility in...

Method to keep track of comorbidities is successful.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Many cancer patients have other diseases, and those ailments can influence their chance of survival and response to treatment. Although physicians take a person's overall health into account when...

Epimmune earns milestone payment under cancer epitope license.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN) announced that it has earned and received a milestone payment from Anosys, Inc., as a result of Anosys' filing of an IND for a product incorporating Epimmune technology under a...

Baicalein and baicalin are strong angiogenesis inhibitors.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Baicalein and baicalin are strong angiogenesis inhibitors. "In recent studies, we have shown that baicalein and baicalin, 2 major flavonoids of Scutellaria baicalensis Georgi, exhibit anticancer...

Company adds Paclitaxel Injection to its U.S. product line.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Faulding Pharmaceutical Co. announced that it is in the process of adding Paclitaxel Injection to its line of oncology products and hopes to begin marketing the product in the United States in October....

Ethics of phase 1 oncology studies examined.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- The ethics of phase 1 oncology studies have been examined in a recent issue of the Journal of the American Medical Association. "Phase 1 oncology trials are critical to improving the treatment of...

Javlor (Vinflunine) enters in phase III clinical trials.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Pierre Fabre Medicament announced the launch of two phase III trials of its new cytotoxic agent Javlor in the treatment of non-small cell lung cancer and bladder cancer. The non-small cell lung...

New data presented on 1D09C3 in combination with rituxan.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- GPC Biotech, AG, (GPC) announced that promising new data on its anticancer monoclonal antibody, 1D09C3, were presented at the Biotherapy Development Association's Seventh International Meeting and First...

Radiation and celebrex combination therapy reduces lung and breast tumor growth.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Radiation and celebrex combination therapy reduces lung and breast tumor growth. According to published research from the United States, "the selective cyclooxygenase (COX)-2 inhibitor, celecoxib,...

Sphingosine kinase inhibitors may hold key to halting growth of some tumors.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Penn State College of Medicine researchers have identified compounds that could wipe out an enzyme responsible for tumor growth. "These compounds our team found are the first 'drug-like' agents...

Starve a tumor or feed a tumor?
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Within a tumor, chaos reigns: Nutrients are scarce, and healthy tissue is muscled out by cancerous tissue so aggressive that the tumor even sacrifices parts of itself to continue its relentless...

Tubercin being tested on mice with cancer.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Hard to Treat Diseases, Inc., (HTDS) announced that it has commenced talks with a medical group in a concerted effort regarding the testing of Tubercin in experiments with mice infected with cancer. ...

Fatigue is common complaint of patients with cancer.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- A new review finds clinicians rarely discuss fatigue with their patients, even though it has a significant impact on quality of life and effective treatments are available. The literature review of...

DVL-1 appears to be involved in cervical squamous cell cancer.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- The DVL-1 gene appears to be involved in some cervical squamous cell carcinoma, but is not expressed in normal tissue. "The Dvl-1 gene on chromosome 1p36 belongs to a family of highly conserved...

Research aims to understand how mistakes in DNA replication lead to disease.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Studies at the University of Houston (UH) are shedding light on the mechanisms our bodies use to recognize and repair mistakes in our genetic code, mistakes that, left unchecked, could lead to cancer....

P16 inactivation may be associated with development of uterine cervical cancers.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- P16 inactivation may be associated with development of uterine cervical cancers. According to recent research from India, "In our analysis, alterations in the P16 tumor suppressor gene were seen in...

Researchers design a novel applicator for low-dose-rate brachytherapy.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Researchers design a novel applicator for low-dose-rate brachytherapy. According to recent research published in the International Journal of Gynecological Cancer, "The standard low-dose-rate (LDR)...

Engineered antibodies may expedite development of therapeutic oncology agents.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Panacea Pharmaceuticals, Inc., has extended and expanded its collaborative research agreement with researchers at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, covering...

A low but significant number of colorectal carcinomas are positive for EMR2.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- A low but significant number of colorectal carcinomas are positive for EMR2. "EMR2 and CD97, members of the epidermal growth factor (EGF)-TM7 family, show a very high homology. CD97, whose...

Calcium, vitamin D, and folate may inhibit colon cancer.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Calcium, vitamin D, and folate may inhibit colon cancer. According to published research from the United States, "Recent findings have indicated that dietary calcium, vitamin D, and folate can...

Detection of hepatic disseminated tumor cells is a powerful prognostic factor.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Detection of hepatic disseminated tumor cells is a powerful prognostic factor. According to a study from Germany, "Approximately 30-50% of all colorectal cancer patients with a resectable primary...

Doctor's urging may boost screening for those at risk.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Encouragement from family physicians could persuade more relatives of colorectal cancer patients to take a life-saving screening test for the disease, according to a new study. More than 143,000...

Function of APC may be regulation of caspase activity, other apoptotic proteins.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- One of the functions of adenomatous polyposis coli (APC) may be the regulation of caspase activity and other apoptotic proteins. "The adenomatous polyposis coli gene, a member of the WNT pathway,...

Microsphere design holds promise for the colonic delivery of 5-fluorouracil.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Microsphere design holds promise for the colonic delivery of 5-fluorouracil. "The treatment of colon cancer has been aimed by approaches of oral drug administration. 5-Fluorouracil is the standard...

PEITC may play an important role in cancer cell killing.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- PEITC may play an important role in the killing of cancerous cells. According to a study from the United States, "Phenethyl isothiocyanate (PEITC) is a potential chemopreventive agent that is...

Poloxamer-containing liposomes can be used for heat-sensitive drug delivery.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Poloxamer-containing liposomes as a heat-sensitive drug delivery system in vivo for colon tumors. According to published research from the United States, "A heat-sensitive liposomal drug delivery...

A medical nutriment has supportive value in the treatment of colorectal cancer.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- A medical nutriment has supportive value in the treatment of colorectal cancer. "MSC (Avemar) is a medical nutriment of which preclinical and observational clinical studies suggested an...

CRAC1 is unlikely to be implicated in the development of colorectal cancer.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- CRAC1 is unlikely to be implicated in the development of colorectal cancer. "A susceptibility gene to colorectal adenomas and carcinoma (CRAC1) on chromosome region 15q14 similar to q22 has been...

FDA approves clinical trial to test therapeutic vaccine Collidem.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- IDM (Immuno-Designed Molecules), a biopharmaceutical company in the field of cellular immunotherapy, announced that it has received approval from the U.S. Food and Drug Administration (FDA) to launch a...

Noninvasive stool test for colorectal cancer now available.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Exact Sciences Corporation (EXAS) and Laboratory Corporation of America Holdings (LabCorp, LH) announced that PreGen-Plus, the DNA-based stool test for the early detection of colorectal cancer, is now...

Mitochondrial DNA detector commercialized to mark adverse effects of therapy.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Primagen Holding B.V., a provider of molecular diagnostic tests for infectious diseases, AIDS, and cancer, has entered into an exclusive worldwide licensing agreement to commercialize the mitochondrial...

Peptide mass signature genotyping can detect TP53 mutations in tumor DNA.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Peptide mass signature genotyping can detect TP53 mutations in tumor DNA. According to a study from the United States, "This report describes the application of a new approach to tumor genotyping...

New topical immunomodulators for use in dermatology.
October 7, 2003... 2003 OCT 7 - (NewsRx.com & NewsRx.net) -- Immunomodulatory drugs are useful in fighting dermatological disease and cancer, and in some cases can supplant or supplement corticosteroid therapy. According to published research from Germany,...